The tightly condensed chromatin of spermatozoa is rapidly decondensed after the spermatozoa enter oocytes. Although no factor involved in sperm chromatin decondensation (SCD) has been identified in mammals, it has been suggested that a factor related to SCD activity is present in the germinal vesicle (GV) of oocytes. Here, we found that the nucleolus-like body (NLB), which is a component of the GV, is involved in SCD in murine oocytes. When NLBs were microsurgically removed from GVstage oocytes, SCD was significantly retarded in the paternal genome after fertilization following meiotic maturation. We found that the retardation of SCD in the NLB-removed oocytes was restored by the microinjection of mRNA encoding nucleoplasmin 2 (NPM2), a component of NLBs. Furthermore, SCD was retarded in the fertilized oocytes from Npm2-knockout females, and recombinant NPM2 alone could induce the SCD in vitro. These data provide evidence that NPM2 is involved in sperm chromatin remodeling in mammals.
INTRODUCTION
The tightly packaged chromatin of spermatozoa is rapidly decondensed within 30 min of entry into oocytes in mice [1] . This process, called sperm chromatin decondensation (SCD), is induced by specific maternal protein(s) in the oocytes. Several proteins have been reported to be implicated in SCD in nonmammalian oocytes. In Xenopus, demembraned sperm chromatin is decondensed by incubation with nucleoplasmin (Np), nucleosome assembly protein 1 (NAP1), or templateactivating factor 1b (TAF1B) in vitro [2, 3] . Np has also been suggested to be essential for SCD, because SCD did not occur in Xenopus egg extracts in which Np had been immunodepleted [2] . In Drosophila, studies analyzing HIRA-or CHD1-knockout oocytes revealed that HIRA and CHD1 are required for the full decondensation of sperm chromatin in the oocytes [4, 5] . It has also been demonstrated in Drosophila that other chromatin remodeling factors, p22 and DF31, can decondense the demembraned Xenopus sperm chromatin in vitro [6, 7] . Thus, it seems that there are several factors involved in SCD, and that they differ between species. However, no factor has yet been identified in mammals.
It is likely that the factor(s) responsible for SCD is present in the germinal vesicle (GV) of the oocytes. When GV-stage oocytes were inseminated, SCD did not occur. However, it did occur when spermatozoa entered into the cytoplasm of oocytes during meiotic maturation after GV breakdown (GVBD) [8] , suggesting that the factor(s) involved in SCD was present within GVs and diffused into the cytoplasm after GVBD. Consistent with this hypothesis is the observation that SCD did not occur when spermatozoa intruded into one-cell embryos in which the pronucleus had already been formed [8] . Furthermore, it has been shown that GV-removed porcine oocytes had no SCD activity, even after the initiation of meiotic maturation [9] . However, there is currently no candidate for the factor(s) with SCD activity in GVs of mammalian oocytes.
The nucleolus-like body (NLB) is the structure specific for GVs in oocytes. Because NLB components exist in the GVs and diffuse into the cytoplasm after GVBD, they are candidates for the factor(s) responsible for SCD. NLBs are structurally and functionally different from the nucleoli of somatic cells. Although the somatic nucleolus is the site of active ribosomal RNA (rRNA) synthesis and ribosome production, NLBs lack ribosomal DNA and, consequently, they are not involved in rRNA synthesis [10, 11] . Although it is notable that NLBs are essential for early embryonic development, because murine and porcine oocytes from which NLBs had been microsurgically removed failed to develop into the blastocyst stage [12] , the precise function of NLBs has not been determined. Ogushi and Saitou retransplanted NLBs into NLB-removed mouse oocytes at various stages before and after fertilization to determine the time point at which NLB components are critically required for progression of early embryonic development [13] . The results showed that the oocytes developed into pups when they were transplanted with NLBs before fertilization, but rarely developed to the blastocyst stage when they were transplanted after pronucleus formation. This suggests that NLB components have a critical role in the cellular process during fertilization or the very early one-cell stage, corresponding to the time at which SCD occurs.
In the present study, we hypothesized that NLB components were involved in SCD after fertilization and contribute to early embryonic development in mammals. We found that nucleoplasmin 2 (NPM2), a component of NLBs, is involved in SCD.
MATERIALS AND METHODS

Collection and Culture of Oocytes and Embryos
Fully grown oocytes at the GV stage were obtained from 8-to 12-wk-old B6D2F1 mice (SLC Japan, Inc., Shizuoka, Japan) 44-48 h after injection with 7.5 IU of equine chronic gonadotropin (eCG; ASKA Pharmaceutical Co., Ltd., Tokyo, Japan). The ovaries were removed from the mice and transferred to a Hepes-buffered potassium simplex optimized medium (KSOM) medium [14] , supplemented with 0.2 mM 3-isobutyl-1-methylxanthine (IBMX; SigmaAldrich, St. Louis, MO). The ovarian follicles were punctured with a 27-gauge needle, and the cumulus cells were gently removed from the cumulusoocyte complexes using a narrow-bore glass pipette. GV-stage oocytes were then transferred into a-minimal essential medium (aMEM; Gibco-BRL, Grand Island, NY) containing 0.2 mM IBMX, 5% fetal bovine serum (FBS; SigmaAldrich), and 10 ng/ml epidermal growth factor (EGF; Sigma-Aldrich). After 1 h of incubation, only those oocytes exhibiting a perivitelline space (PVS) were used in the following experiments, because those without a PVS rarely complete meiotic maturation [15] .
For in vitro maturation, the oocytes were washed in IBMX-free aMEM supplemented with 5% FBS and 10 ng/ml EGF and incubated for 16-18 h in a humidified atmosphere of 5% CO 2 /95% air at 378C.
For in vitro fertilization, MII-stage oocytes were transferred to human tubal fluid (HTF) medium [16] supplemented with 10 mg/ml bovine serum albumin (BSA; Sigma-Aldrich) and inseminated with spermatozoa obtained from the caudal epididymides of adult ICR male mice (SLC Japan, Inc.). The spermatozoa had been capacitated before they were used for insemination by incubation for 2 h in the HTF medium. Subsequently, 6 h after insemination, the fertilized oocytes were washed and cultured in KSOM.
For in vitro fertilization of oocytes from Npm2 þ/À and Npm2 À/À mice (provided by Martin M Matzuk), MII-stage oocytes were obtained from 8-wkold females that had been injected with 7.5 IU of eCG followed 48 h later by 7.5 IU of human chorionic gonadotropin (hCG; ASKA Pharmaceutical). The oocytes were isolated from the ampullae of oviducts 15 h post-hCG injection. They were transferred to an HTF medium supplemented with 4 mg/ml BSA and inseminated with capacitated spermatozoa, obtained from the caudal epididymides of adult wild-type ICR male mice.
All of the procedures involving animals were reviewed and approved by the University of Tokyo Institutional Animal Care and Use Committee, and were performed in accordance with the Guiding Principles for the Care and Use of Laboratory Animals.
Micromanipulation
All micromanipulations were performed using a micromanipulator equipped with a Piezo impact drive (Prime Tech Ltd., Ibaraki, Japan). The GV was removed with minimal cytoplasm after the oocytes were preincubated in Hepes-buffered KSOM containing 0.2 mM IBMX, 10 lg/ml cytochalasin B (CB; Sigma-Aldrich), and 0.1 lg/ml colcemid (Sigma-Aldrich) at 378C for 15 min. The NLBs of GV-stage oocytes were removed in Hepes-buffered KSOM containing 0.2 mM IBMX and 7.5 lg/ml CB, as described previously [12] . When an isolated NLB was fused with oocytes, Sendai virus (HVJ; Ishihara Sangyo Co., Ltd., Osaka, Japan) was used. The manipulated oocytes were cultured in aMEM containing IBMX for 1 h to ensure complete fusion.
Plasmid Constructs
To obtain GV oocyte cDNA, total RNA was isolated from GV-stage oocytes using ISOGEN (Nippon Gene, Tokyo, Japan) according to the manufacturer's instructions. The isolated RNA was dissolved in diethylpyrocarbonate-treated water, and reverse-transcribed using a PrimeScript RT-PCR kit (Takara, Otsu, Japan).
Full-length (624 bp) mouse Npm2 was amplified by PCR with KOD-Plus-DNA polymerase (TOYOBO, Tokyo, Japan) from total GV oocyte cDNA. The sequences of primers used were 5 0 -ATGAGTCGCC ACAGCACC-3 0 and 5 0 -TCATTTCTTG GTCACTGGC-3 0 . The PCR products were then subjected to electrophoresis and purified using a DNA Clean Kit (GENECLEAN; MP Biomedicals, Solon, OH). The Npm2 open reading frame was then added with an epitope tag at the 5 0 end by PCR with TaKaRa Ex Taq DNA polymerase (TaKaRa) using a primer encoding the 8-amino acid Flag epitope with linker polypeptide (Gly-Gly-Ser-Gly-Gly) and the 5 0 -end of Npm2. The sequences of the primers for Flag-Npm2 amplification were 5 0 -ATGGATTACA AGGAT GACGA CGATAAGGGA GGATCGGGAG GAAGTCGCCA CAGCAC CAG-3 0 and 5 0 -TCATTTCTTG GTCACTGGC-3 0 . The PCR product was then subjected to electrophoresis and purified using the DNA Clean Kit. The purified PCR product of Flag-Npm2 was cloned into the pCRII vector using a TOPO TA cloning kit (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions, and the construct was verified by DNA sequence analysis.
Preparation and Microinjection of mRNA
Capped mRNA was prepared from BamHI-linearized DNA constructs by in vitro transcription using a T7 mMessage mMachine kit (Ambion, Austin, TX).
Poly(A) tails were added to the capped mRNA using a Poly(A) Tailing Kit (Ambion) according to the manufacturer's instructions. To remove the template DNA, the reaction mixture was treated with Turbo DNase (provided with the in vitro transcription kit). The synthesized mRNA was purified using lithium chloride (provided with the in vitro transcription kit). The mRNA sample was diluted with nuclease-free water to a final concentration of 500 ng/ll and stored at À808C until use.
Microinjection was performed under an inverted microscope (Eclipse TE300; Nikon Corp., Tokyo, Japan) using a micromanipulator and microinjector (both from Narishige Co., Tokyo, Japan). GV-stage oocytes were transferred to Hepes-buffered KSOM containing 0.2 mM IBMX and injected with ;10 pl of mRNA using narrow glass capillaries (GC100 TF-10; Harvard Apparatus Ltd., Kent, U.K.).
Immunocytochemistry
Embryos were fixed in 3.7% paraformaldehyde in PBS for 1 h, washed with PBS containing 1 mg/ml BSA (PBS/BSA), permeabilized with 0.5% Triton X-100 for 15 min at room temperature, and then incubated overnight at 48C with a primary antibody diluted in PBS/BSA, anti-histone H3 lysine 9 dimethylation (H3K9me2) rabbit polyclonal antibody (1:100; Upstate Biotechnology, Lake Placid, NY), anti-H3K9me2 mouse monoclonal antibody (1:100; Abcam, Cambridge, MA), anti-histone H4 lysine 20 trimethylation (H4K20me3) rabbit polyclonal antibody (1:400; Upstate Biotechnology), anti-H2A mouse monoclonal antibody (1:400; MBL, Nagoya, Japan), anti-H2A.X rabbit polyclonal antibody (1:100; Abcam), or anti-H2B mouse monoclonal antibody (1:300; MBL). The samples were then incubated with a 1:200 dilution of a fluorescein isothiocyanate-conjugated anti-rabbit IgG (Jackson ImmunoResearch, West Grove, PA), Alexa Fluor 488 anti-mouse IgG (Molecular Probes, Eugene, OR), Alexa Fluor 568 anti-rabbit IgG (Molecular Probes), or Cy3-conjugated anti-mouse IgG (Jackson Immuno-Research) for 1 h. The oocytes were mounted on a glass slide in Vectashield antibleaching solution (Vector Laboratories, Burlingame, CA) containing 100 lg/ml propidium iodide (PI; Sigma-Aldrich) or 3 lg/ml 4 0 ,6 0 -diamidino-2-phenylindole (DAPI; Dojindo Laboratories, Kumamoto, Japan). When DNA was counterstained with PI, cells were preincubated with 50 lg/ml RNase (Roche Diagnostics, Mannheim, Germany) for 40 min at room temperature. Fluorescence was detected under a laser-scanning confocal microscope (LSM510; Carl Zeiss MicroImaging GmbH, Oberkochen, Germany). Measurement in the area of sperm chromatin was conducted using Scion Image (Scion Corp., Frederick, MD).
Immunoblotting
Oocytes were collected in 10 ll of 13 SDS sample buffer (50 mM Tris-HCl [pH 6.8], 2% SDS, 5% 2-mercaptoethanol, 10% glycerol, 0.01% bromophenol blue), incubated at 958C for 3 min, and stored at À208C until use.
The proteins were separated by SDS-PAGE on 8% or 10% polyacrylamide gels and electrically transferred to polyvinylidene fluoride membranes (Millipore, Bedford, MA). The membranes were blocked for 60 min at room temperature in Tris-buffered saline (TBS; 25 mM Tris-HCl and 150 mM NaCl [pH 7.6]) containing 5% BSA. They were washed in TBS/0.1% Tween-20 (TBS-T) and then incubated with goat anti-NPM2 antiserum (provided by Martin M. Matzuk) diluted at 1:4000 with TBS-T containing 0.5% BSA overnight at 48C. After being washed with TBS-T four times, the membranes were incubated with a horseradish peroxidase-conjugated anti-goat IgG (Cell Signaling Technology, Danvers, MA) diluted at 1:16 000 with TBS-T containing 0.5% BSA for 1 h at room temperature. The membranes were washed four times in TBS-T, and the antibodies bound to the membranes were detected using an ECL Advance Western Blotting Detection Kit (Amersham Biotech, Little Chalfont, Buckinghamshire, U.K.). Luminescence was detected using an LAS-1000 Plus LuminoImage analyzer (Fujifilm, Kanagawa, Japan). Quantification of the band densities in the images of immunoblotting was conducted using Scion Image.
Expression and Purification of His-NPM2 Protein
Npm2 cDNA was amplified by PCR with KOD-Plus-DNA polymerase from the plasmid encoding Flag-Npm2 using BamHI site-anchored primers. The PCR product was purified, digested with BamHI, and cloned into the BamHI site of pET15b vector (Novagen). 4 Cl, 10 mM MgCl 2 , 7 mM 2-mercaptoethanol) and lysed by sonication on ice. Cell debris was removed by centrifugation (15 000 rpm, 45 min) and the supernatant was applied to a Ni 2þ column (HiTrap Chelating HP; GE Healthcare Bio-Sciences) and washed with 100 ml of buffer A containing 25 mM imidazole. The protein was eluted with a linear gradient, from 25 to 300 mM imidazole, in buffer A, followed by a dialysis overnight against buffer B (50 mM Hepes-KO [pH 7.6], 1 M NH 4 Cl, 100 mM KCl, 10 mM MgCl 2 , 7 mM 2-mercaptoethanol). A dialysis was then performed against buffer B containing 30% (v/v) glycerol for 3 h. The protein was precipitated with 65% (w/v) ammonium sulfate and stored at 48C. Before being used for the experiments, the protein was recovered from the precipitant using an NAP-5 column (GE Healthcare Bio-Sciences) with buffer C (50 mM Hepes-KOH [pH 7.6], 500 mM KCl, 5 mM MgCl 2 , 7 mM 2-mercaptoethanol). The concentration of the purified protein was determined by the Bradford assay, using BSA as a standard.
In Vitro Sperm Decondensation Assay
Capacitated sperm were washed three times in buffer C. Approximately 5 3 10 5 spermatozoa were incubated in a final volume of 100 ll buffer C in the absence or presence of 15 or 40 lM His-NPM2 at 378C with gentle agitation. Subsequently, after 24 h of incubation, 2-ll aliquots were mixed with an equal volume of 2.5% glutaraldehyde and 4 ll of Vectashield containing 3 lg/ml DAPI.
Statistical Analysis
Data were analyzed using v 2 tests. Differences were considered statistically significant at P , 0.01.
RESULTS
NLB Components Are Required for SCD
To examine whether components of the NLB were involved in SCD after fertilization, we microsurgically removed NLBs from GV-stage oocytes and examined their ability to decondense sperm chromatin after fertilization following in vitro maturation. As controls, we prepared the nonmanipulated oocytes and the NLB-restored oocytes, which had been subjected to microsurgery to remove the NLB and then fused with an isolated NLB. The oocytes were fixed at 5 h postinsemination (hpi) and stained with DAPI and the antibody against dimethylated lysine 9 of histone H3 (H3K9me2), which was used to distinguish the paternal pronucleus from the maternal one. H3K9me2 was detected only in the maternal genome, not the paternal one, at the one-cell stage [17] . We observed that most nonmanipulated oocytes (97%) and all NLB-restored oocytes had a paternal pronucleus with decondensed chromatin (Fig. 1, A and B) . In contrast, highly condensed chromatin was observed in paternal pronuclei in some NLB-removed oocytes. Based on the extent of chromatin condensation, we classified the chromatin states into three groups: largely condensed, partially condensed, and decondensed (Fig. 1A) . Only 42% of NLB-removed oocytes FIG. 1 . Involvement of NLB in SCD. NLBs of GV-stage oocytes were microsurgically removed (NLB-removed). In some of these oocytes, the NLB was restored by fusion with an isolated NLB (NLB-restored) as a control. Oocytes that were not subjected to these manipulations (Non-manipulated) were also prepared as a control for the manipulation procedure. The oocytes matured in vitro and were then inseminated. A) Morphology of the pronuclei in fertilized oocytes at 5 h postinsemination. The oocytes were immunostained with antiH3K9me2 antibody to distinguish between the maternal and paternal pronuclei. The paternal pronuclei are indicated by yellow arrows. DNA was stained with DAPI. The chromatin morphology was classified into three types: condensed chromatin (Condense), partially condensed chromatin (Partially Condense), and fully decondensed chromatin (Decondense). Representative images of each group of oocytes are shown. Bar ¼ 30 lm. B) Percentages of oocytes showing each type of chromatin morphology in the paternal (P) and maternal (M) pronuclei. The experiment was performed more than three times with similar results. In each experiment, 6-16 oocytes were used, and the data were combined. The total numbers of oocytes examined were 39, 99, and 27 in nonmanipulated, NLBremoved, and NLB-restored, respectively. C) Morphology of chromosomes at the onecell mitotic phase. The one-cell embryos were stained with an antibody against H4K20me3 (green), which is localized in the pericentromeric regions of maternal chromatin only. DNA was stained with PI (red). The yellow arrows indicate the aggregated paternal chromosomes. Bar ¼ 30 lm.
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exhibited a paternal pronucleus with decondensed chromatin, and 30% and 27% of those had the largely condensed and partially condensed paternal chromatin, respectively (Fig. 1B) . No condensed chromatin was observed in maternal pronuclei of the oocytes in any experimental group (Fig. 1, A and B) . In the oocytes with condensed chromatin, the SCD did not cease, but progressed slowly with the lack of NLB components; the percentage of the oocytes with condensed chromatin decreased to 3% at 11 hpi. Instead, the percentage of oocytes with decondensed and partially condensed chromatin increased to 55% and 42%, respectively. Nevertheless, aggregated chromosomes, which seemed to be derived from partially condensed chromatin, were observed in the paternal chromatin of some NLB-removed oocytes when they entered into the mitotic phase at 15 hpi; 31% (9/29) of those oocytes had irregularly aggregated paternal chromosomes at the prophase of mitosis (Fig. 1C) . None of the nonmanipulated oocytes (0/13) or the NLB-restored oocytes (0/19) had such aggregated chromosomes. Together, these results demonstrate that the NLB components are required for the normal progression of SCD after fertilization.
NLB Components Facilitate SCD in GV-Removed Oocytes
When the GV is removed from a fully grown oocyte, the oocyte does not acquire SCD activity after cytoplasmic maturation. This suggests that GV materials are required for SCD [9] . Thus, to confirm that NLB components contribute to SCD activity in the GV, we transplanted an NLB into the GVremoved oocytes to see whether SCD activity was restored by this manipulation. After an NLB was fused into the oocyte in ) an isolated NLB. The oocytes were matured in vitro and were then inseminated. After 4 h, they were fixed and stained with PI. A) Morphology of the spermatozoa intruding in the GV-removed oocytes. Type I, condensed chromatin with little increase in size; type II, partially condensed chromatin, which had some phase-dense regions; type III, decondensed chromatin without condensed regions. Bar ¼ 10 lm. B) The percentage of each type of sperm chromatin in NLB þ and NLB À oocytes. C) Histogram of the sperm chromatin area in NLB þ and NLB À oocytes. The experiment was performed four times with similar results. In each experiment, 5-20 oocytes were used, and the data were combined. The total numbers of sperm chromatin analyzed were 35 and 60 in the NLB þ and NLB À oocytes, respectively.
FIG. 3. Facilitation of SCD by microinjection of Npm2 mRNA in NLBremoved oocytes.
A) The percentages of condensed, partially condensed, and decondensed chromatin in the paternal and maternal pronuclei. NLBremoved oocytes were injected with mRNA encoding Flag-Npm2 or distilled water (DW) and then matured in vitro. The oocytes that had reached the MII-stage were inseminated, fixed 5 h later, and stained with anti-H3K9me2 antibody and DAPI. The chromatin in the paternal and maternal pronuclei was classified according to the criteria shown in Figure  1A . The experiment was performed five times with similar results. In each experiment, 5-14 oocytes were used, and the data were combined. The total numbers of oocytes examined were 48 and 43 in DW and Flag-Npm2 mRNA groups, respectively. B) Protein expression from the microinjected mRNA in the oocytes. Nonmanipulated and NLB-removed oocytes injected with Flag-Npm2 mRNA or DW matured in vitro. Twelve MIIstage oocytes were used for immunoblotting with an anti-NPM2 antibody. The anti-a-tubulin antibody was also used as a loading control. Major bands and slower migrating weak bands indicate endogenous NPM2 and exogenous FLAG-NPM2, respectively. Molecular mass (kDa) is shown on the left side.
which the GV had been removed, the transplanted NLB diffused into the cytoplasm and disappeared within 1 h in medium containing IBMX, an inhibitor of spontaneous maturation. As a control, we prepared GV-removed oocytes not transplanted with an NLB. These oocytes were transferred into an IBMX-free medium to undergo cytoplasmic maturation for 16-18 h, and then inseminated to examine their SCD activity. At 4 hpi, the fertilized oocytes were fixed and DNA was stained. In these oocytes, because of the removal of GVs, which caused the lack of nuclear membrane components, pronuclei did not form. Based on the size and morphology of the sperm chromatin, we classified the fertilized oocytes into three groups ( Fig. 2A) : type I showed fully or largely condensed chromatin, and its size was almost the same as the original sperm head; type II showed partially condensed, swollen chromatin with a few DNA-dense lumps; and type III showed grossly decondensed, swollen chromatin without DNA-dense lumps. In the control group (NLB À ), 45% and 47% of oocytes had type I and type II spermatozoa, respectively. Type III spermatozoa were observed in only 8% of oocytes (Fig. 2B) . On the other hand, type III spermatozoa were observed in most (94%) of the NLB-transplanted oocytes (NLB þ ; Fig. 2B ). The quantification analysis for the area of sperm chromatin clearly showed that the area was larger in the NLB þ oocytes than in the NLB À ones (Fig. 2C) . The average area of sperm chromatin in NLB þ oocytes was 1.7 times as large as that in NLB À oocytes. These results show that NLB components contribute to the SCD activity in the GV.
NPM2 Facilitates SCD in NLB-Removed Oocytes
Because we previously showed that NPM2, which is expressed specifically in oocytes and early preimplantation embryos, is a component of NLBs [18] , we hypothesized that NPM2 may be involved in SCD. Thus, we examined whether exogenous NPM2 expression recovered the retardation of SCD observed in NLB-removed oocytes. After removal of NLBs from GV-stage oocytes in the medium containing IBMX, we injected synthesized mRNA for Npm2 with a Flag-tag at the N terminus. As a control, RNase-free distilled water, the solvent used for the mRNA, was injected into the NLB-removed oocytes. At 16-18 h after the oocytes were transferred into the IBMX-free medium to allow the resumption of meiosis, they reached the MII phase and were inseminated. At 5 hpi, the oocytes were fixed and stained with DAPI and anti-H3K9me2 antibody. According to the classification for the chromatin states in paternal pronuclei as shown in Figure 1A , 40%, 17%, and 44% of the control oocytes had pronuclei with decondensed, partially condensed, and condensed chromatin, respectively (Fig. 3A) . In contrast, 81% of oocytes injected with Flag-Npm2 mRNA exhibited decondensed chromatin, which was significantly greater than that of control oocytes (P , 0.01, v 2 test). No chromatin was condensed in either the control or mRNA-injected oocytes in any of the maternal pronuclei (Fig.  3A) .
In these experiments, it is formally possible that an excess amount of exogenous FLAG-NPM2 abnormally induced chromatin decondensation in the NLB-removed oocytes. To address this, the expression level of FLAG-NPM2 protein was examined in oocytes that had been microinjected with mRNA. To compare the amount of FLAG-NPM2 with endogenous NPM2, we microinjected Flag-Npm2 mRNA into the GV-stage oocytes in which NLB had not been removed. These oocytes were allowed to reach the MII stage in the IBMX-free medium, and were collected for immunoblotting with the anti-NPM2 antibody. The results show that exogenous FLAG-NPM2 protein was expressed, and its expression level was apparently less than that of endogenous NPM2 (Fig. 3B; lane 2) . Additionally, we confirmed that NPM2 was almost completely lost in the NLB-removed oocytes ( Fig. 3B; lanes 3 and 4) .
Together, these results demonstrate that exogenous NPM2 expression restored the activity of chromatin decondensation in 74 the paternal pronuclei of the NLB-removed oocytes, suggesting that NPM2 is the NLB component responsible for SCD.
NPM2 Induces SCD In Vitro
To determine whether NPM2 possesses the ability to decondense sperm chromatin, we conducted an in vitro sperm decondensation assay using recombinant NPM2 protein. First, we prepared recombinant NPM2 with a 63 histidine tag at the N terminus (His-NPM2) by overexpression in E. coli and purification using HPLC. SDS-PAGE showed successful production and purification of His-NPM2 (Fig. 4A, arrow) , but there was a small amount of a faster migrating band (Fig.  4A, arrowhead) . This band appeared to be a truncated form of the recombinant protein, because it was recognized by anti-NPM2 antibody on immunoblotting (Fig. 4B, arrowhead) as well as the major band (Fig. 4B, arrow) . Next, we estimated the concentration of endogenous NPM2 in MII-stage oocytes by comparison between the serial-diluted samples of purified His-NPM2 and the extract from 20 MII-stage oocytes on immunoblotting with anti-NPM2 antibody (Fig. 4B) . The calibration curve shown in Figure 4C indicates that the amount of endogenous NPM2 in MII-stage oocytes was ;75 pg/ oocyte, and, therefore, the intracellular concentration was calculated at ;15 lM, based on a volume of 220 pl for MIIstage oocytes [19] and the estimated molecular weight of 23.3 kDa of NPM2. When spermatozoa were incubated with 15 lM His-NPM2 at 378C for 24 h, they were decondensed and their size became obviously larger than the control spermatozoa, which were incubated in solvent (0 lM) and remained fully condensed (Fig. 4D) . With 40 lM of His-NPM2, the spermatozoa were grossly decondensed and swollen (Fig.  4D) . It seems unlikely that this decondensation was caused by nonspecific effects as a result of high protein amounts in vitro, because sperm chromatin was not decondensed when incubated with 1 mg/ml BSA, an amount equivalent to 40 lM His-NPM2 (data not shown). These results indicate that NPM2 had the ability to induce decondensation of spermatozoa in vitro with no other factor from the oocytes.
NPM2 Is Involved in SCD after Fertilization
To verify the need for NPM2 in SCD, we analyzed fertilized oocytes from Npm2-knockout mice. MII-stage oocytes were collected from Npm2 À/À and Npm2 þ/À mice and fertilized with the spermatozoa from wild-type ICR mice. Fertilized oocytes were fixed at 5 hpi and stained with DAPI and an antibody against H3K9me2. The observed chromatin states in pronuclei were classified as shown in Figure 1A . In Npm2 À/À oocytes, 44%, 51%, and 5% showed a paternal pronucleus with decondensed, partially condensed, and condensed chromatin, respectively, whereas all Npm2 þ/À oocytes exhibited decondensed chromatin (Fig. 5A ). All Npm2 þ/À and 98% of Npm2 À/À oocytes had a maternal pronucleus with decondensed chromatin (Fig. 5B) . We also observed that some (34%) Npm2 À/À oocytes still had a paternal pronucleus with partially condensed chromatin at 11 hpi (data not shown). These results indicate that NPM2 is involved in SCD after fertilization.
DISCUSSION
In this study, we found that NLBs contain a factor with SCD activity. When an NLB was removed from the oocyte, SCD was significantly retarded in the paternal genome after fertilization. Furthermore, we show that NPM2 is the factor responsible for the SCD activity in NLB. Expression of NPM2 from microinjected mRNA restored the retardation of SCD in the NLB-removed oocytes. Additionally, NPM2 alone could decondense sperm chromatin in vitro, and retardation of SCD was observed in fertilized oocytes from Npm2-knockout mice. These results provide the first evidence that NPM2 is a factor responsible for sperm chromatin remodeling, which has not been previously identified in mammals.
Although we have shown that NPM2 has SCD activity, SCD still occurred at a slower rate in the NLB-removed oocytes (Fig. 1B and as described in Results) in which NPM2 was almost completely lost (Fig. 3B) , as well as in fertilized oocytes derived from Npm2 À/À oocytes (Fig. 5) . This observation suggests that there is another factor(s) involved in SCD, and that it could partially compensate for the absence of NPM2. Several candidates arise from previous studies. For example, NAP1 and TAF1B may be involved in SCD, because mouse NAP1 and human TAF1B can induce the decondensation of demembraned Xenopus sperm in vitro [3] . Another candidate is NPM3, one of the Np family proteins, as well as NPM2 [20] . It has been reported that histone incorporation into sperm chromatin and formation of the paternal pronucleus did not occur in some of NPM3 knockdown oocytes in which antisense oligonucleotides for NPM3 had been microinjected [21] . Although we did not obtain a similar result in our preliminary experiments using short interfering RNA specific for NPM3, it is still possible that NPM3 functions redundantly with NPM2 in the process of SCD. We have shown that the removal of NLB did not completely inhibit the occurrence of SCD, but induced retardation of SCD progression (Fig. 1B and as described in Results) . A similar phenomenon was observed in Npm2 À/À oocytes. The percentage of Npm2 À/À oocytes exhibiting a paternal pronucleus with decondensed chromatin increased from 44% at 5 hpi to 66% at 11 hpi (Fig. 5 and data not shown). This could account for the conflict with a previous report describing that SCD occurred normally in Npm2 À/À oocytes [22] . Burns et al. collected fertilized oocytes from mated females at 18-24 h post-hCG treatment, which would be expected to be at the mid-to-late one-cell stage [22] , while we used the in vitro fertilization system and fixed at 5 hpi, which corresponded to the early onecell stage. Thus, the discrepancy may result from the difference in the fixation time at the one-cell stage. Alternatively, there were some other differences, such as culture condition, male strain, and fixation method, which may also have contributed to the different conclusion.
We observed that some fertilized oocytes from Npm2 À/À females still had a paternal pronucleus with partially condensed chromatin at the late one-cell stage (11 hpi). This observation may account for the low fertility rate in Npm2 À/À females. On average, the number of litters decreases to ;30% of control Npm2 À/À females [22] . This retardation of SCD would cause the developmental arrest of Npm2 À/À fertilized oocytes. The role of murine NPM2 in SCD seems to differ from that of Xenopus Np, which functions as a histone chaperone to replace sperm-specific proteins X and Y with maternal histone H2A/H2B [23, 24] . The immunostaining of NLB-removed, fertilized oocytes, which lack NPM2 protein (Fig. 3B) , with the specific antibodies against histones H2A, H2A.X, and H2B, revealed that these histones were deposited not only in the decondensed regions, but also in the condensed ones of the paternal chromatin (data not shown). This suggests that histones can be incorporated into chromatin without NPM2, and that NPM2 does not function as a histone chaperone. Alternatively, NPM2 might function as a protamine acceptor, which has been suggested to be a different molecule from a histone chaperone [25] . We could not evaluate for this possibility, because we were not able to successfully use the available antibody against protamines for detection by immunocytochemistry. Localization of protamines in the condensed regions of paternal chromatin in NLB-removed or Npm2 À/À fertilized oocytes would help in determining whether NPM2 is involved in the removal of protamines.
It is likely that NPM2 is involved only in the paternal chromatin remodeling, but not in the maternal one, since the condensed chromatin was observed only in the paternal pronucleus, but not the maternal one, of NLB-removed or Npm2 À/À fertilized oocytes (Figs. 1 and 5 ). There are two hypotheses explaining how NPM2 acts only on the paternal chromatin remodeling. The first is that NPM2 localizes only in the paternal pronucleus, and not in the maternal one. The other hypothesis is that NPM2 interacts with a factor that exists only in paternal chromatin (e.g., protamines), although NPM2 localizes both paternal and maternal pronuclei. The latter possibility is more likely, because we detected NPM2 protein fusing with the green fluorescence protein in both paternal and maternal chromatin both shortly after fertilization and at the pronuclear stage (Inoue and Aoki, unpublished results).
Posttranslational modifications may be important for NPM2 to acquire high SCD activity, because murine NPM2 is phosphorylated in MII-stage oocytes [26 and our data not shown]. In Xenopus, it has been shown that Np is highly phosphorylated during maturation, and the increase in the phosphorylated group correlates well with the SCD activity [27, 28] . Although the chromatin was decondensed within 30 min after the spermatozoa had intruded into the oocytes in vivo [1] , in our experiment, it took much longer for recombinant His-NPM2 to decondense sperm chromatin in vitro (Fig. 4) . This difference may be attributable to the lack of posttranslational modification of the recombinant protein.
It is intriguing that NPM2, a protein involved in the remodeling of sperm chromatin, localizes in the NLBs at the GV stage, because it leads to the consideration of the stillunknown function of NLBs. A factor with the activity for sperm chromatin remodeling would not be needed in GV-stage oocytes; rather, it might be harmful for maternal chromatin. Thus, it may be sequestered in NLBs and segregated from the other proteins in the nucleoplasm at the GV stage when it is not needed, which would protect the maternal chromatin or nuclear proteins from its possible detrimental effect. Indeed, we have shown that, when an NPM2 mutant lacking NLB-targeting ability had been expressed in growing oocytes, only a few oocytes could reach the full-grown stage, suggesting that the NPM2 that had accumulated in the nucleoplasm disturbed oocyte growth [18] . It has been proposed in yeast and mammalian somatic cells that the nucleolus serves as a mechanism to prevent some enzymes from functioning at inappropriate times by sequestering them from other proteins in the nucleoplasm [29, 30] . Thus, the NLB also might function as the place to segregate some proteins (e.g., NPM2) that are not required during the growth phase, but work during maturation and/or after fertilization.
